… chemotherapy on cognitive dysfunction and identify any potential age‑related differences in
patients with breast cancer treated with adjuvant chemotherapy. … debar a critical appraisal of …

… Previous researchers have suggested that AIs (anastrazole) may have superior efficacy than
tamoxifen in the adjuvant hormonal treatment of early breast cancer [7]. On the other hand, …

… The treatment of hormone receptor positive breast cancer has evolved significantly in recent
… early breast cancer receiving either adjuvant chemotherapy and anastrozole or adjuvant …

… , the cognitive domain most consistently affected by estrogen … from pre-treatment cognitive
performance over the course of … after just 1 year of treatment, it is critical that additional studies …

… in women with hormone receptor-positive early breast cancer. … assessed cognitive abilities
in postmenopausal breast cancer … in women: A critical review. Front Neuroendocrinol 2008;29:…

… The Critical Window Theory suggests that estrogen … effect of adjuvant therapies on cognitive
function 7, 37. In a recent cross-sectional study conducted after mixed adjuvant therapies, …

… and blockers of estrogen synthesis on cognitive function, and … behaviors and brain functions,
including sexual behavior/… Consistent with the critical window hypothesis, in the WHIMS …

… Adjuvant endocrine therapy (ET) is the … cognitive complaints and tested cognitive functioning
are often not strongly correlated, and in clinical practice, the assessment of both is critical to …

… BC are hormone receptor positive, and therefore, endocrine therapy (ET) plays a critical role
in … changed over time in women with BC receiving adjuvant therapy as compared to women …

… of subjective cognitive function in older survivors of breast cancer … initiation of adjuvant
treatment is therefore crucial to identify … effect on adherence to hormone therapy for breast cancer. …